Fig. 10From: ADSCs stimulated by VEGF-C alleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C/VEGFR-3-dependent mechanism and inhibiting the NF-κB pathway by the secretomeSchematic depiction of the underlying mechanisms by which VEGF-C-stimulated ADSCs alleviate chronic colitis via lymphangiogenesis and immunomodulatory effects. VEGF-C-stimulated ADSCs could simultaneously improve lymphatic drainage (“OUT”) and inhibit the inflammatory response (“IN”) by activating VEGF-C/VEGFR-3-dependent signals and suppressing the NF-κB pathwayBack to article page